Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients

2014 ◽  
Vol 30 (8) ◽  
pp. 693-700 ◽  
Author(s):  
Katsuyuki Yanagisawa ◽  
Junya Ashihara ◽  
Shinji Obara ◽  
Norio Wada ◽  
Masayoshi Takeuchi ◽  
...  
Keyword(s):  
Glycaemic Control ◽  
Insulin Glargine ◽  
Basal Insulin ◽  
Treatment Satisfaction ◽  
Vascular Damage ◽  
Injection Therapy ◽  
Daily Injection ◽  
Diabetic Patients ◽  
Multiple Daily Injection

scholarly journals Direction for Basal Insulin Therapy by Once Daily Injection in the Clinical Practice

2021 ◽  
Vol 3 (1) ◽  
pp. 11-15
Author(s):  
Bando H
Keyword(s):  
Clinical Practice ◽  
Basal Insulin ◽  
Insulin Injection ◽  
Daily Injection ◽  
Diabetic Patients ◽  
Once Daily ◽  
Multiple Daily Injection ◽  
Elder Patients ◽  
Wide Range ◽  
Dual Action

American Diabetes Association (ADA) has announced the new version of the standards of Medical Care in Diabetes-2021. The guideline of the diabetic patients with Older Adults seems to be used for a wide range of clinical practice. Among them, several impressive comments were found, where “Once-daily basal insulin injection therapy is associated with minimal side effects and maybe a reasonable option in many elder patients”. Recent topic includes Dual Action of Liraglutide and insulin degludec (DUAL) studies, and Xultophy has shown beneficial efficacy. Consequently, the trend would be developed from multiple daily injection (MDI) method to once daily injection.

scholarly journals Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience

2011 ◽  
Vol 13 (6) ◽  
pp. 601-606 ◽  
Author(s):  
John B. Buse ◽  
George Dailey ◽  
Andrew A. Ahmann ◽  
Richard M. Bergenstal ◽  
Jennifer B. Green ◽  
...  
Keyword(s):  
Injection Therapy ◽  
Daily Injection ◽  
Pump Therapy ◽  
Multiple Daily Injection

scholarly journals When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control

2019 ◽  
Vol 21 (6) ◽  
pp. 1305-1310 ◽  
Author(s):  
Guillermo E. Umpierrez ◽  
Neil Skolnik ◽  
Terry Dex ◽  
Louise Traylor ◽  
Jason Chao ◽  
...  
Keyword(s):  
Glycaemic Control ◽  
Insulin Glargine ◽  
Dose Response ◽  
Basal Insulin ◽  
Response Relationship ◽  
Dose Response Relationship

scholarly journals Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial

2020 ◽  
Vol 22 (8) ◽  
pp. 1369-1377 ◽  
Author(s):  
Martin Haluzík ◽  
Alice Cheng ◽  
Dirk Müller‐Wieland ◽  
Jukka Westerbacka ◽  
Zsolt Bosnyak ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Insulin Glargine ◽  
Kidney Function ◽  
Basal Insulin
Sign in / Sign up

Export Citation Format

Share Document